These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11119053)

  • 21. [Molecular screening of the major mutations in the ARSA gene in patients with metachromatic leukodystrophy].
    Horovenko NH; Ol'khovych NV; Pichkur NO
    Tsitol Genet; 2002; 36(5):43-8. PubMed ID: 12442547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and biological evaluation of enantiomeric beta-N-acetylhexosaminidase inhibitors LABNAc and DABNAc as potential agents against Tay-Sachs and Sandhoff disease.
    Rountree JS; Butters TD; Wormald MR; Boomkamp SD; Dwek RA; Asano N; Ikeda K; Evinson EL; Nash RJ; Fleet GW
    ChemMedChem; 2009 Mar; 4(3):378-92. PubMed ID: 19145603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galactosialidosis in two siblings.
    Yuce A; Kocak N; Besley GT
    Turk J Pediatr; 1996; 38(1):85-9. PubMed ID: 8819626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gene diagnosis of lysosomal diseases].
    Suzuki Y
    Nihon Rinsho; 1995 Dec; 53(12):2921-5. PubMed ID: 8577036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult onset metachromatic leukodystrophy without electroclinical peripheral nervous system involvement: a new mutation in the ARSA gene.
    Marcão AM; Wiest R; Schindler K; Wiesmann U; Weis J; Schroth G; Miranda MC; Sturzenegger M; Gieselmann V
    Arch Neurol; 2005 Feb; 62(2):309-13. PubMed ID: 15710861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro analysis of multipotent mesenchymal stromal cells as potential cellular therapeutics in neurometabolic diseases in pediatric patients.
    Müller I; Kustermann-Kuhn B; Holzwarth C; Isensee G; Vaegler M; Harzer K; Krägeloh-Mann I; Handgretinger R; Bruchelt G
    Exp Hematol; 2006 Oct; 34(10):1413-9. PubMed ID: 16982334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Missense mutations as a cause of metachromatic leukodystrophy. Degradation of arylsulfatase A in the endoplasmic reticulum.
    Poeppel P; Habetha M; Marcão A; Büssow H; Berna L; Gieselmann V
    FEBS J; 2005 Mar; 272(5):1179-88. PubMed ID: 15720392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of nine novel arylsulfatase a (ARSA) gene mutations in patients with metachromatic leukodystrophy (MLD).
    Eng B; Nakamura LN; O'Reilly N; Schokman N; Nowaczyk MM; Krivit W; Waye JS
    Hum Mutat; 2003 Nov; 22(5):418-9. PubMed ID: 14517960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early discoveries on enzyme deficiencies in lysosomal storage diseases: The Indian contribution.
    Gupta S; Bachhawat AK
    J Biosci; 2023; 48():. PubMed ID: 38088379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel mutations in arylsulfatase A gene in three Ukrainian families with metachromatic leukodystrophy.
    Olkhovich NV; Takamura N; Pichkur NA; Gorovenko NG; Aoyagi K; Yamashita S
    Mol Genet Metab; 2003 Nov; 80(3):360-3. PubMed ID: 14680985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postnatal and prenatal diagnosis of lysosomal storage diseases in the former Soviet Union.
    Krasnopolskaya XD; Mirenburg TV; Akhunov VS; Voskoboeva EY
    Wien Klin Wochenschr; 1997 Feb; 109(3):74-80. PubMed ID: 9060146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current strategies in the management of lysosomal storage diseases.
    Heese BA
    Semin Pediatr Neurol; 2008 Sep; 15(3):119-26. PubMed ID: 18708002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lysosomal storage disease: a group of genetic neurodegenerative disorders].
    Suzuki Y
    Nihon Rinsho; 1993 Sep; 51(9):2264-8. PubMed ID: 8411700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency.
    Deconinck N; Messaaoui A; Ziereisen F; Kadhim H; Sznajer Y; Pelc K; Nassogne MC; Vanier MT; Dan B
    Eur J Paediatr Neurol; 2008 Jan; 12(1):46-50. PubMed ID: 17616409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of Mycoplasma and mycoplasma removal agent on the hydrolase activity in fibroblasts of patients with lysosomal diseases.
    Souza FT; Sostruznik LS; Scolari RC; Castro KJ; Andrade CV; Giugliani R; Coelho JC
    Rev Argent Microbiol; 2010; 42(1):18-22. PubMed ID: 20461288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis of lysosomal diseases].
    Caillaud C
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S288-9. PubMed ID: 17961865
    [No Abstract]   [Full Text] [Related]  

  • 37. Lysosomal sulfatide storage in the brain of arylsulfatase A-deficient mice: cellular alterations and topographic distribution.
    Wittke D; Hartmann D; Gieselmann V; Lüllmann-Rauch R
    Acta Neuropathol; 2004 Oct; 108(4):261-71. PubMed ID: 15322834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysosomal high molecular weight multienzyme complex.
    Ostrowska H; Krukowska K; Kalinowska J; Orłowska M; Lengiewicz I
    Cell Mol Biol Lett; 2003; 8(1):19-24. PubMed ID: 12655352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipocalin-type prostaglandin D synthase is up-regulated in oligodendrocytes in lysosomal storage diseases and binds gangliosides.
    Mohri I; Taniike M; Okazaki I; Kagitani-Shimono K; Aritake K; Kanekiyo T; Yagi T; Takikita S; Kim HS; Urade Y; Suzuki K
    J Neurochem; 2006 May; 97(3):641-51. PubMed ID: 16515539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases.
    Ramsay SL; Maire I; Bindloss C; Fuller M; Whitfield PD; Piraud M; Hopwood JJ; Meikle PJ
    Mol Genet Metab; 2004 Nov; 83(3):231-8. PubMed ID: 15542394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.